Company intelligence / Profile preview

TecTraum

United Statespro2coolrx.com ↗
Ownership
Private
Employees
~5
Development stage
Phase 3
01

Overview

TecTraum has developed pro2cool®, a novel, noninvasive hypothermic therapy device for the treatment of concussion. The system provides localized cooling to the head and neck to lower blood temperature before it enters the brain, aiming to reduce severity and duration of concussion symptoms. A large multisite pivotal clinical trial in adolescents was completed in April 2022, showing significant improvements in clinical outcomes. The company is preparing data for FDA submission with plans for commercial launch pending regulatory clearance[1][3][6].

Therapeutic areas
Neurology
Modalities
DeviceNon-pharmacological therapyHypothermic therapy device (localized cooling)
Industry
Therapeutic Medical Devices
02

Drug pipeline

1 asset

pro2cool

Phase 3
Indications
Concussion, Mild traumatic brain injury
03

Partnerships

Nottingham-Spirk (design and development partner)[3][5]

Beyond the preview

Go deeper on TecTraum.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TecTraum.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call